Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
May 20, 2025
Contrarian Stock Trading Using Agentic AI

Contrarian Stock Trading Using Agentic AI

Trading, while often perceived as a numbers game, is deeply emotional. The decisions to buy or sell stocks aren't always based on cold, hard facts. Instead, they're frequently influenced by an investor's feelings, biases, and perceptions. This is where sentiment indicators like the Fear & Greed Index come into play.

 

By providing a quantifiable measure of market sentiment, AI Agents can avert traders from their own emotions that might be swaying their decisions. For instance, during times of extreme fear, a trader might be inclined to sell stocks, even if fundamentals suggest otherwise. Conversely, during periods of heightened greed, the same investor might be tempted to buy, potentially overlooking overvaluation risks.

 

The Role of Agentic Ai in Contrarian Copy Trading 

 

As Warren Buffett warned: "You pay a very high price in the stock market for a cheery consensus." Contrarians try to do the opposite of the crowd. They get excited when an otherwise good company has a sharp drop in the stock prices. The more prices swing, the more misguided they believe the rest of the market to be.

 

A contrarian trader believes the people predict a downturn, they have already sold out, at which point the market can only go up. For this reason, a contrarian mindset is great for sussing out whether or not a particular stock has actually bottomed out.

 

Copy trading enables individuals in the financial markets to automatically copy positions opened and managed by other selected individuals of AI Agents. Unlike mirror trading, a method that allows traders to copy specific strategies, copy trading links a portion of the copying trades to their accounts either manually or automatically. 

 

In 2012, MIT funded a study that showed that traders on the copy trading platforms who benefited from "guided copying", i.e. copying a suggested investor or AI Agent, fared 6-10% better than traders who were mirror trading, and 4% better than traders who were copy trading random investors.

Agentic AI is revolutionizing market strategies with advanced multi-agent systems, enabling smarter, faster decision-making. Companies like OpenAI and others are using a technique called ‘agentic’ to make cheaper and more efficient AI models. This method is the industry’s new buzzword and enables AI models to run with fewer resources. 

In 2018, another study discovered that losses are usually higher for copied trades in the event of negative returns without hedging. As a result, the Dual Agent Trading Bots address these problems because of a dual-strategy system that thrives in both bullish and bearish conditions simultaneously. 

For instance, it combines a Price Action Agent to capture upward trends with a Hedging Agent that mitigates risk using inverse ETFs. These Agents act independently and Hedging Agents will always fill the positions, unlike selling short which might not be filled, or buying expensive puts. 

By leveraging real-time market analysis and adaptive pattern recognition, this bot enhances trade execution, minimizes exposure, and ensures a resilient, automated trading framework in volatile markets.

Trading Inverse ETFs vs. Short Selling 

Imagine you're betting that a stock or market is going to drop. One way to do that is by using an inverse ETF. This type of exchange-traded fund uses different financial tools to make money when the market falls. In a way, owning an inverse ETF is like holding several short positions at once. 

Example of Top 6 Gainers of the brutal day of March 10th, 2025 

1. PTGX  +46.13%              2. TSLQ  +32.24% 

3. $WLYB +24.05%              4. SARK +17.82% 

5. BNKD +15.38%              6. SOXS +14.30% 

 

Why Inverse ETFs Might Be Better:

 

  • No Margin Account Needed: With inverse ETFs, you don't need a special margin account—this is usually required for short selling. A margin account lets you borrow money from your broker to trade, which adds extra risk.
  • Simplicity: Inverse ETFs let you bet against the market without the hassle of borrowing stocks.

What About Short Selling? Short selling involves borrowing stocks you don't own, selling them, and then buying them back later at a hopefully lower price. The goal is to profit from the price drop. But if the price goes up instead, you'll have to buy the stocks back at a higher price, which can lead to losses.

Additional Costs with Short Selling:

  • Stock Loan Fee: You pay a fee to your broker for borrowing the shares.
  • High Costs: Stocks that are heavily shorted might be hard to borrow, driving up the fee, sometimes over 3% of the borrowed amount. This can quickly make short selling expensive and risky, especially for newcomers.
  •  

The Dual-Strategy Machine Learning Framework

 

The Dual Agent Trading Bot employs two specialized AI-driven agents that operate in tandem to balance profitability and risk management. This multi-agent architecture ensures strategic adaptability by dynamically responding to changing market conditions, maximizing gains during upward trends while mitigating potential losses in downturns.

Pattern Recognition Agent: Spotting Contrarian Opportunities

Unlike traditional momentum-based strategies, the Pattern Recognition Agent leverages advanced machine learning algorithms to analyze both historical and real-time market data. Its primary function is to identify recurring patterns that statistically precede price surges. Key features include:

  • Sophisticated Price Action Analysis – Uses candlestick formations, trendlines, and volume dynamics to detect high-probability trade setups.
  • Optimized Entry & Exit Points – When a bullish pattern is confirmed, the agent executes a long position with precision, ensuring efficient trade execution.
  • Adaptive Learning Mechanism – Continuously refines its pattern detection models based on evolving market behavior, reducing false positives and enhancing accuracy.

By incorporating these cutting-edge AI techniques, the Pattern Recognition Agent ensures that the bot capitalizes on upward price movements with minimal lag and high efficiency.

 

Hedging Agent: Protecting Against Downturns

 

While the Pattern Recognition Agent focuses on seizing profit opportunities, the Hedging Agent is engineered to safeguard the portfolio from market downturns. Instead of directly shorting assets, this agent employs defensive trading mechanisms, including:

  • Inverse ETFs & Alternative Instruments – Takes long positions in securities that move opposite to the underlying asset, ensuring gains during market declines.
  • Counter-Cyclical Profit Generation – When the primary asset falls, the hedging instruments appreciate, offsetting potential losses from long positions.
  • Continuous Market Monitoring – Analyzes risk factors such as volatility spikes, macroeconomic trends, and sudden price reversals to preemptively adjust hedging strategies.

By seamlessly switching between offensive and defensive trading approaches, the Dual Agent Trading Bot ensures portfolio resilience in all market conditions. Whether prices are rising or falling, this AI-powered system remains strategically positioned to capture gains while minimizing downside risks.

 

The Role of Agentic AI in Autonomous Trading

 

At the core of the Dual Agent Trading Bot lies Agentic AI, a system that enables seamless real-time interactions among multiple specialized agents. This autonomous intelligence allows the bot to react to market shifts in milliseconds, giving traders a significant edge in the world of high-frequency trading (HFT).

Key Advantages of Agentic AI:

  1. Real-Time Responsiveness:
    • The system reacts instantly to market fluctuations, executing trades within milliseconds.
    • This is particularly valuable in volatile environments where speed is a competitive advantage.
  2. Robust Risk Management:
    • The complementary bullish and bearish strategies offset downturns, ensuring portfolio balance.
    • Automated stop-losses and risk parameters further enhance capital protection.
  3. Enhanced Precision in Trading Execution:
    • Advanced data analytics and AI-driven insights ensure highly accurate trade execution.
    • This minimizes slippage and execution errors, which are common in manual trading.
  4. Elimination of Human Bias:
    • The bot strictly adheres to data-driven strategies, avoiding emotional trading errors.
    • Ensures a disciplined, objective trading approach that maintains consistency.

By leveraging multi-agent AI collaboration, the Dual Agent Trading Bot achieves superior accuracy and efficiency in algorithmic trading.

 

Advantages of the Dual Agent Trading Bot in Autotrading

 

With the increasing adoption of auto trading systems, traders are seeking solutions that offer automation, precision, and adaptability. The Dual Agent Trading Bot provides several unique advantages that enhance its effectiveness in fully automated environments.

1. Continuous Market Surveillance

  • The bot operates 24/7, continuously monitoring global markets for new trading opportunities.
  • Ensures that no lucrative trades are overlooked due to human limitations.

2. Instantaneous Execution

  • By executing trades instantly based on real-time data, the system eliminates delays caused by manual intervention.
  • This leads to faster order fulfillment, a critical factor in high-frequency trading (HFT).

3. Consistent Strategy Implementation

  • Unlike human traders, the bot follows predefined trading strategies with unwavering discipline.
  • Maintains strategy integrity across various market conditions, enhancing long-term performance.

4. Scalability for Diversified Trading

  • The dual-agent model can be scaled across multiple assets and markets, improving portfolio diversification.
  • Additional AI agents can be integrated for more sophisticated strategy enhancements.

These capabilities make the Dual Agent Trading Bot a revolutionary tool for both retail and institutional traders looking for fully automated, high-performance trading solutions.

 

Transforming Trading Environments with AI

 

The significance of the Dual Agent Trading Bot extends well beyond its dual-strategy design. In an era dominated by algorithmic and high-frequency trading, its ability to dynamically adapt to both bullish and bearish market signals sets it apart from conventional models.

Key Innovations That Differentiate the Bot:

  • Multi-agent collaboration ensures dynamic adaptability across different market conditions.
  • AI-driven risk management minimizes losses while capitalizing on profitable setups.
  • Real-time decision-making allows for instant trade execution, optimizing profits.

By leveraging the collective intelligence of specialized AI agents, this system provides unparalleled precision and risk management, making it a transformative force in modern auto trading.

 

The Future of Multi-Agent Trading

 

As financial markets grow increasingly complex, the evolution of Agentic AI and multi-agent trading systems is poised to redefine trading standards. The Dual Agent Trading Bot serves as a pioneering example of how integrating machine learning with strategic hedging can create robust, adaptive trading models.

Future Developments in AI-Driven Trading:

  • Integration of Reinforcement Learning: AI bots could self-optimize strategies based on past performance.
  • Decentralized AI Collaboration: Multi-agent systems may become interoperable with blockchain-based trading networks.
  • Incorporation of Sentiment Analysis: Future bots may analyze news sentiment and social media trends to refine trading signals.

With ongoing advancements in machine learning, real-time data analytics, and AI decision-makingmulti-agent trading models will continue to offer more sophisticated tools for risk management and profit maximization.

 

Tickeron and Financial Learning Models (FLMs)

 

Sergey Savastiouk, Ph.D., CEO of Tickeron, emphasizes the importance of technical analysis in managing market volatility. Through Financial Learning Models (FLMs)Tickeron integrates AI with technical analysis, allowing traders to spot patterns more accurately and make better-informed decisions.

Tickeron’s AI-Powered Trading Enhancements:

  • Beginner-friendly trading bots provide an accessible entry point for new traders.
  • High-liquidity stock robots ensure seamless execution of trades in fast-moving markets.
  • Real-time AI-driven insights help traders enhance control and transparency in trading decisions.

By incorporating machine learning and real-time AI analytics, Tickeron’s innovations further reinforce the growing dominance of AI-driven trading.

 

Conclusion: A Paradigm Shift in Autotrading

 

The Dual Agent Trading Bot represents a significant evolution in auto trading and algorithmic finance. By marrying advanced pattern recognition with strategic hedging, it delivers a resilient, high-performance solution designed to meet the demands of modern financial markets.

  • Precision and risk management define its dual-strategy success.
  • Agentic AI integration ensures seamless automation with real-time adaptability.
  • Scalability and efficiency make it a versatile tool for traders across various markets.

In summary, the future of trading is here—intelligent, adaptive, and decisively dual-edged.

Disclaimers and Limitations

Related Ticker: PTGX, WLYB, TSLQ, SARK, SOXS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


PTGX's Indicator enters downward trend

The Aroon Indicator for PTGX entered a downward trend on September 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 191 similar instances where the Aroon Indicator formed such a pattern. In 160 of the 191 cases the stock moved lower. This puts the odds of a downward move at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for PTGX moved out of overbought territory on August 19, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 50 similar instances where the indicator moved out of overbought territory. In 37 of the 50 cases, the stock moved lower in the following days. This puts the odds of a move lower at 74%.

The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTGX as a result. In 69 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for PTGX turned negative on August 24, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 34 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.

PTGX moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +2.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTGX advanced for three days, in 240 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

PTGX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 9 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 18 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. PTGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.050) is normal, around the industry mean (26.842). P/E Ratio (139.631) is within average values for comparable stocks, (40.142). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.179). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (34.130) is also within normal values, averaging (437.043).

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.25B. The market cap for tickers in the group ranges from 58 to 130.87B. VRTX holds the highest valuation in this group at 130.87B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was 7%. NRSN experienced the highest price growth at 1,794%, while LGVN experienced the biggest fall at -66%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 107%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 78
Price Growth Rating: 58
SMR Rating: 93
Profit Risk Rating: 92
Seasonality Score: -12 (-100 ... +100)
View a ticker or compare two or three
PTGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of disulfide-rich peptides

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
7707 Gateway Boulevard
Phone
+1 510 474-0170
Employees
132
Web
https://www.protagonist-inc.com
Interact to see
Advertisement
Shares of NSA stock surged roughly 27% in premarket trading after the company agreed to be acquired by Public Storage in an all-stock transaction valued at about $10.5 billion. The deal values National Storage Affiliates at an implied price of about $41.68 per share, representing a substantial premium to its prior closing price near the low-$30s.
Shares of NBIS jumped roughly 12% in premarket trading after a sharp rally in the prior regular session. The latest leg of the price rally follows news of a multibillion‑dollar, long‑term AI infrastructure agreement with Meta Platforms that expands Nebius’s cloud capacity commitments.
Micron Technology’s common stock MU (MU) rose 5.13% in the latest completed session, closing at 426.13 dollars versus 405.35 dollars previously. The move appears driven by continued enthusiasm around Micron’s role as a key memory supplier to artificial intelligence and data center markets, supporting an earnings-driven re‑rating of the stock.
IperionX Limited (IPX) is down about 15.57% in early trading on March 16, with shares recently changing hands near 29.44 dollars versus a previous close of 34.87 dollars. The drop extends a post‑earnings selloff after the company’s March 12 results highlighted continued losses and substantial funding needs to scale its titanium operations.
Shares of CTMX surged roughly 56% in the latest session, staging a sharp intraday price rally from the prior close. The move appears driven by earnings-related positioning and growing optimism around CytomX’s PROBODY therapeutic platform and late‑stage oncology pipeline.
Hyperliquid Strategies Inc (PURR) shares jumped about 15% in the latest session, extending a multi-week price rally tied to digital-asset exposure. The move comes as traders bid up proxy plays on the Hyperliquid ecosystem and HYPE token, with renewed risk appetite in crypto-related assets.
VIA fell over 11% today, extending a slide that began last week; the stock has been under pressure since trading around the high‑teens and low‑$20s, well below its $46 IPO price.
LAES fell more than 19% today as the market digested a $125 million registered direct offering of 30.4 million new shares (or pre‑funded warrants) plus warrants for up to 60.8 million additional shares, all priced at $4.11 per unit.
Shares of ALDX are down about 73.02% in premarket trading, plunging from a prior close near 4.13 dollars to roughly 1.11 dollars after a major regulatory setback. The collapse follows fresh confirmation that the U.S. Food and Drug Administration has again declined to approve reproxalap for dry eye disease, issuing another Complete Response Letter that questions efficacy.
Shares of MVST are down about 25% in premarket trading today compared with the prior close. The slide follows a sharp reassessment of the company’s outlook as investors react to new information and recent volatility in high‑beta battery and EV names.
Solaris Energy Infrastructure’s stock SEI jumped roughly 13% in today’s session, extending a sharp recent rebound from early-March lows. The move is driven by ongoing post-earnings momentum after strong Q4 and full‑year 2025 results and raised guidance highlighted rapid growth in its power solutions business.
Shares of LMND are trading approximately +10% higher intraday on Tuesday, March 17, 2026, rising from a prior close of $57.74 to around $63.51. Primary catalyst: Morgan Stanley upgraded LMND to an 'Overweight' rating and raised its price target to $85 from $80.
Shares of ICHR surged approximately +15% intraday on Tuesday, March 17, 2026, trading near $48.98 versus a prior closing price of $42.59. The primary catalyst is a high-profile analyst upgrade by Stifel, with analyst Brian Chin upgrading the stock to Buy citing improved cyclical strength and conviction in the company's revenue and margin trajectory.
NBIS shares are down approximately 10.00% in Tuesday's session, falling from a prior close of $129.85 to around $116.87. The primary catalyst is Nebius Group's pre-market announcement of a proposed $3.75 billion convertible senior notes offering, sparking dilution concerns.
TME shares fell over 20% today, with the stock sliding from the mid‑$15s toward the low‑$13s in the wake of its Q4 2025 report and earnings call, extending a pre‑market drop of roughly 12–13%.
HUYA shares fell over 11% today, dropping from the mid‑$3 range toward the low‑$3s following the company’s Q4 2025 earnings release before the U.S. market open. Q4 total net revenues rose about 16% year over year to roughly CNY 1.74 billion, with full‑year 2025 revenues up around 7% to CNY 6.5 billion, but the market had already priced in a rebound after a difficult 2024.​
CWCO fell over 9% today, trading around the low‑$31 range versus recent levels in the mid‑$30s to near $39, as the market reacted negatively to Q4 2025 results and forward commentary. Full‑year 2025 results showed stable earnings and dividend growth but a roughly 9% decline in services revenue to about $46.3 million, reflecting a slowdown in project‑based construction work.
SMTC shares dropped over 8% today after the company reported Q4 results that met or modestly beat Street estimates but showed the slowest year‑over‑year revenue growth in several quarters, at about 9.3% to roughly $274–275 million.
AXTI shares slipped more than 6% today, reversing part of a powerful rally that had recently driven the stock to a 52‑week high above $47 and more than doubled its price year‑to‑date. Q4 2025 revenue of about $23.0 million missed consensus by roughly $1.2 million and fell 8–18% year over year and sequentially, while the company posted another GAAP net loss of around $3.5 million (–$0.08 per share).
Shares of SailPoint, Inc. (SAIL) are tumbling approximately 12% in premarket trading on March 18, 2026, after the company released its fiscal fourth-quarter and full-year 2026 results before the market opened. While Q4 revenue came in slightly above consensus at $295 million (+23% year-over-year), investors were rattled by disappointing forward guidance for fiscal 2027.